Neratinib for the treatment of early-stage, hormone receptor-positive, HER2-overexpressed breast cancer
Jerez, Yolanda, Herrero, Blanca, Arregui, Marta, Morón, Blanca, MartÃn, Miguel, EchavarrÃa, IsabelJournal:
Future Oncology
DOI:
10.2217/fon-2020-0046
Date:
May, 2020
File:
PDF, 1.60 MB
2020